Apomorphine for prolonged disorders of consciousness: a multimodal open-label study.
Sanz LRD, Lejeune N, Szymkowicz E, Bonin EAC, Panda R, Sala A, Thibaut A, Huerta-Gutierrez R, Dardenne N, Dikenstein D, Van Goethem S, Ledoux D, Hustinx R, Stender J, Farber NM, Zafonte RD, Schiff ND, Laureys S, Gosseries O.
Sanz LRD, et al. Among authors: sala a.
EClinicalMedicine. 2024 Nov 15;78:102925. doi: 10.1016/j.eclinm.2024.102925. eCollection 2024 Dec.
EClinicalMedicine. 2024.
PMID: 39624459
Free PMC article.